Compile Data Set for Download or QSAR
Report error Found 9 Enz. Inhib. hit(s) with all data for entry = 6432
TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128384BDBM128384(US8802721, 1)
Affinity DataIC50: 3nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128386BDBM128386(US8802721, 3)
Affinity DataIC50: 6.40nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128385BDBM128385(US8802721, 2)
Affinity DataIC50: 14nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128388BDBM128388(US8802721, 117)
Affinity DataIC50: 16.5nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128387BDBM128387(US8802721, 4)
Affinity DataIC50: 58.5nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128391BDBM128391(US8802721, 120)
Affinity DataIC50: 87nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128390BDBM128390(US8802721, 119)
Affinity DataIC50: 94.8nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128389BDBM128389(US8802721, 118)
Affinity DataIC50: 104nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent

TargetInterleukin-2(Human)
Synta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 128392BDBM128392(US8802721, 121)
Affinity DataIC50: 164nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2015
Entry Details
US Patent